16-2112360-A-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_001009944.3(PKD1):​c.3275T>C​(p.Met1092Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0875 in 1,514,852 control chromosomes in the GnomAD database, including 13,074 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 5154 hom., cov: 33)
Exomes 𝑓: 0.075 ( 7920 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.85

Publications

17 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 10 uncertain in NM_001009944.3
BP4
Computational evidence support a benign effect (MetaRNN=0.020166844).
BP6
Variant 16-2112360-A-G is Benign according to our data. Variant chr16-2112360-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 256947.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.3275T>C p.Met1092Thr missense_variant Exon 14 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.3275T>C p.Met1092Thr missense_variant Exon 14 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29974
AN:
152056
Hom.:
5135
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.462
Gnomad AMI
AF:
0.123
Gnomad AMR
AF:
0.136
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0284
Gnomad FIN
AF:
0.0758
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.0991
Gnomad OTH
AF:
0.192
GnomAD2 exomes
AF:
0.0721
AC:
15410
AN:
213684
AF XY:
0.0656
show subpopulations
Gnomad AFR exome
AF:
0.397
Gnomad AMR exome
AF:
0.0671
Gnomad ASJ exome
AF:
0.105
Gnomad EAS exome
AF:
0.0000560
Gnomad FIN exome
AF:
0.0399
Gnomad NFE exome
AF:
0.0674
Gnomad OTH exome
AF:
0.0886
GnomAD4 exome
AF:
0.0752
AC:
102537
AN:
1362680
Hom.:
7920
Cov.:
32
AF XY:
0.0729
AC XY:
49520
AN XY:
678960
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.434
AC:
11896
AN:
27384
American (AMR)
AF:
0.0757
AC:
3259
AN:
43076
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
3057
AN:
24378
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39670
South Asian (SAS)
AF:
0.0259
AC:
2191
AN:
84614
European-Finnish (FIN)
AF:
0.0619
AC:
2297
AN:
37124
Middle Eastern (MID)
AF:
0.147
AC:
565
AN:
3852
European-Non Finnish (NFE)
AF:
0.0705
AC:
73737
AN:
1045430
Other (OTH)
AF:
0.0967
AC:
5528
AN:
57152
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.360
Heterozygous variant carriers
0
4335
8669
13004
17338
21673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2452
4904
7356
9808
12260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.197
AC:
30036
AN:
152172
Hom.:
5154
Cov.:
33
AF XY:
0.190
AC XY:
14124
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.462
AC:
19152
AN:
41456
American (AMR)
AF:
0.136
AC:
2078
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
552
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5182
South Asian (SAS)
AF:
0.0280
AC:
135
AN:
4828
European-Finnish (FIN)
AF:
0.0758
AC:
805
AN:
10618
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.0991
AC:
6741
AN:
67998
Other (OTH)
AF:
0.190
AC:
401
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1007
2014
3021
4028
5035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.148
Hom.:
515
Bravo
AF:
0.217
ExAC
AF:
0.0712
AC:
8153

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 04, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:2
Jul 07, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 05, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 30, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22608885) -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The c.3275T>C, p.Met1092Thr variant was identified in 7.5% of 6086 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015). -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.037
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
12
DANN
Benign
0.67
DEOGEN2
Benign
0.15
T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0020
N
LIST_S2
Benign
0.21
T;T
MetaRNN
Benign
0.020
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
-2.7
N;N
PhyloP100
2.9
PrimateAI
Benign
0.41
T
PROVEAN
Benign
2.5
N;N
REVEL
Benign
0.15
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0010
B;B
Vest4
0.032
ClinPred
0.0033
T
GERP RS
4.4
PromoterAI
-0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.044
gMVP
0.24
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2549677; hg19: chr16-2162361; COSMIC: COSV51916816; COSMIC: COSV51916816; API